
    
      The primary study objective is to evaluate the disease control rate. The secondary study
      objectives are to evaluate safety and toxicity, objective response rate, overall and 6-month
      progression free survival, and overall survival. Exploratory study objectives include
      evaluation of serum and ascites VEGF, hypertension, and paracentesis frequency in subjects
      with ascites at study entry.
    
  